University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic is a clinical research site located in Chicago, Illinois, United States 60637.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers.
Sponsors: Cellvax Therapeutics Inc.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic has 1 clinical trials on record, with 1 currently active. Their work covers Prostate Cancer (Adenocarcinoma), Prostate CA, Prostate Cancers.
University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.